Publications:

AIMP2-DX2 provides therapeutic interface to control KRAS-driven tumorigenesis.

Nature Communications

Kim, Dae Gyu DG; Choi, Yongseok Y; Lee, Yuno Y; Lim, Semi S; Kong, Jiwon J; Song, JaeHa J; Roh, Younah Y; Harmalkar, Dipesh S DS; Lee, Kwanshik K; Goo, Ja-Il JI; Cho, Hye Young HY; Mushtaq, Ameeq Ul AU; Lee, Jihye J; Park, Song Hwa SH; Kim, Doyeun D; Min, Byung Soh BS; Lee, Kang Young KY; Jeon, Young Ho YH; Lee, Sunkyung S; Lee, Kyeong K; Kim, Sunghoon S

Publication Date: 2022-05-11

Variant appearance in text: NRAS: S87A

PubMed Link: 35546148

Variant Present in the following documents:

• 41467_2022_30149_MOESM1_ESM.pdf

View BVdb publication page